The impact of metabolic syndrome on mental health‑related quality of life and depressive symptoms

Results examining associations between metabolic syndrome (MetS) and depression, as well as on quality of life (QoL), are inconsistent. We aimed to determine whether individuals with MetS had decreased mental health-related QoL (MH-QoL) and higher frequency of depressive symptoms.

The association between Metabolic Syndrome (MetS) and mental health is a complex field that requires careful study, as demonstrated by research using data from the Fels Longitudinal Study. Metabolic Syndrome, a cluster of conditions including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels, has been linked to various health issues, including a potential increase in depressive symptoms and a decrease in mental health-related quality of life (MH-QoL).

The study explores whether individuals with MetS show a higher frequency of depressive symptoms and lower MH-QoL. The research involves over a thousand participants and uses tools like the Patient Health Questionnaire-9 (PHQ-9) for assessing depressive symptoms and the Medical Outcomes 36-Item Short Form Survey (SF-36) for MH-QoL. The analysis highlights a significant association between MetS and elevated depressive symptoms in women, although the same wasn't as evident in men. Interestingly, for older men, MetS seemed to have a protective effect against low MH-QoL, suggesting that the impact of MetS can vary significantly based on gender and age.

Such findings underscore the importance of considering individual variations in the psychological impacts of MetS. They also suggest that as the obesity rates continue to rise, understanding how MetS relates to mental health could become increasingly vital in managing both physical and psychological well-being. This emphasizes the need for targeted health strategies that address both metabolic and mental health needs of the population.

« ​ Metabolic Syndrome was significantly associated with elevated depressive symptoms in women (OR 2.14, 95% CI 1.22–3.78, p < 0.01), but not in men ».

References 1. Huang PL (2009). A comprehensive definition for metabolic syndrome. Disease Models & Mechanisms, 2(5–6), 231–237. 10.1242/dmm.001180. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 2. Saboya PP, Bodanese LC, Zimmermann PR, Gustavo AD, Assumpcao CM, & Londero F (2016). Metabolic syndrome and quality of life: A systematic review. Revista Latino-Americana de Enfermagem, 24, e2848 10.1590/1518-8345.1573.2848. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 3. Moore JX, Chaudhary N, & Akinyemiju T (2017). Metabolic syndrome prevalence by race/ethnicity and sex in the United States, national health and nutrition examination survey, 1988–2012. Preventing Chronic Disease, 14, E24 10.5888/pcd14.160287. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 4. Aguilar M, Bhuket T, Torres S, Liu B, & Wong RJ (2015). Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA, 313(19), 1973–1974. 10.1001/jama.2015.4260. [PubMed] [CrossRef] [Google Scholar] 5. Soltani M, Smith S, Beck E, & Johnson M (2015). Universal depression screening, diagnosis, management, and outcomes at a student-run free clinic. Academic Psychiatry, 39(3), 259–266. 10.1007/s40596-014-0257-x. [PubMed] [CrossRef] [Google Scholar] 6. Services, S. O. T. U. S. D. O. H. A. H. (2018). Health, United States, 2017: With Special Feature on Mortality (Health, United States). Hyattsville, MD: National Center for Health Statistics [PubMed] [Google Scholar] 7. John Mann J, Ellis SP, Currier D, Zelazny J, Birmaher B, Oquendo MA, et al. (2016). Self-rated depression severity relative to clinician-rated depression severity: Trait stability and potential role in familial transmission of suicidal behavior. Archives of Suicide Research, 20(3), 412–425. 10.1080/13811118.2015.1033504. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 8. Akincigil A, & Matthews EB (2017). National rates and patterns of depression screening in primary care: Results from 2012 and 2013. Psychiatric Services, 68(7), 660–666. 10.1176/appi.ps.201600096. [PubMed] [CrossRef] [Google Scholar] 9. Smithson S, & Pignone M (2017). Screening adults for depression in primary care. The Medical Clinics of North America, 101(4), 807–821. 10.1016/j.mcna.2017.03.010. [PubMed] [CrossRef] [Google Scholar] 10. Kahl KG, Schweiger U, Correll C, Muller C, Busch ML, Bauer M, et al. (2015). Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus. Brain and Behavior, 5(3), e00306 10.1002/brb3.306. [PMC free article] [PubMed] [CrossRef] [Google Scholar]